IPR2016-01614 Final Written Decision | Feb 22, 2018 | PAPER | BOARD |
Granting Motion for Pro Hac Vice Recognition of
Mr. Charles B. Klein and Mr. Eimeric Reig-Plessis
37 C.F.R. sec 42.10(c) | Jul 18, 2017 | PAPER | BOARD |
Decision Institution of Inter Partes Review, Grant of Motion for Joinder, and Grant of Joint Motion to Dismiss Certain Challenges in the Petition | Jul 18, 2017 | PAPER | BOARD |
Joint Motion to Dismiss | Jul 10, 2017 | PAPER | PATENT OWNER |
Ex. 1058 - Declaration of Charles B. Klein ISO PHV Motion | May 9, 2017 | EXHIBIT | PETITIONER |
Petitioner's Unopposed Motion For Pro Hac Vice Admission Of Charles B. Klein And Eimeric Reig-Plessis | May 9, 2017 | PAPER | PETITIONER |
Ex. 1059 - Declaration of Eimeric Reig-Plessis ISO PHV Motion | May 9, 2017 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List (05 09 2017) | May 9, 2017 | PAPER | PETITIONER |
Notice of Deposition of Elena Massarotti | May 5, 2017 | PAPER | PATENT OWNER |
Power of Attorney | Apr 14, 2017 | PAPER | PATENT OWNER |
Mandatory Notice | Apr 14, 2017 | PAPER | PATENT OWNER |
Notice of Accepting Corrected Petition | Apr 11, 2017 | PAPER | BOARD |
Klareskog, Double-Blind Randomised Controlled Trial | Apr 7, 2017 | EXHIBIT | PETITIONER |
Notice of Defective Petition | Apr 6, 2017 | PAPER | BOARD |
U.S. Patent 7,820,161 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Declaration of Elena Massarotti MD | Mar 24, 2017 | EXHIBIT | PETITIONER |
Elena Massarotti CV | Mar 24, 2017 | EXHIBIT | PETITIONER |
Second Declaration of Ronald F. van Vollenhoven, dated January 19, 2010 | Mar 24, 2017 | EXHIBIT | PETITIONER |
William Schwieterman FDA Conversation | Mar 24, 2017 | EXHIBIT | PETITIONER |
Eisenberg letter to Genetech Oncology & IDEC | Mar 24, 2017 | EXHIBIT | PETITIONER |
Gryn letter to Parker, dated May 6, 1998 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Saleh letter to Comprehensive Cancer Center, dated October 1, 1998 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Latov letter to Horvath, dated November 16, 1998 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Pestronk letter to Department of Neurology, dated October 12, 1998 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Looney letter to Duthcer dated January 15, 1999 | Mar 24, 2017 | EXHIBIT | PETITIONER |
American Colelge of Rheumatology Subcommittee | Mar 24, 2017 | EXHIBIT | PETITIONER |
T. Pincus & C.M. Stein, No Evidence of disease in rheumatoid arthritis | Mar 24, 2017 | EXHIBIT | PETITIONER |
Kremer, Methotrexate for Rheumatoid Arthritis | Mar 24, 2017 | EXHIBIT | PETITIONER |
ODell, Methotrexate Use (1997) | Mar 24, 2017 | EXHIBIT | PETITIONER |
Boers, World Health Organization | Mar 24, 2017 | EXHIBIT | PETITIONER |
Boers et al., The Lancet, 350.309-18 (1997) | Mar 24, 2017 | EXHIBIT | PETITIONER |
Felson American College of Rheumatology | Mar 24, 2017 | EXHIBIT | PETITIONER |
Kremer, Combination Therapy with Biologic Agents in Rheumatoid Arthritis | Mar 24, 2017 | EXHIBIT | PETITIONER |
Guidance for Industry Clinical Development Programs for Drugs | Mar 24, 2017 | EXHIBIT | PETITIONER |
Weinblatt et al., New England Journal of Medicine | Mar 24, 2017 | EXHIBIT | PETITIONER |
Maini et al., Arthritis & Rheumatism | Mar 24, 2017 | EXHIBIT | PETITIONER |
First Declaration of Ronald F. van Vollenhoven, dated July 30, 2007 | Mar 24, 2017 | EXHIBIT | PETITIONER |
IPR2015-00415 Patent Owner's Preliminary Response | Mar 24, 2017 | EXHIBIT | PETITIONER |
Maloney Phase 1 Clinical Trial Using Escalating Single-Dose Infusion (1994) | Mar 24, 2017 | EXHIBIT | PETITIONER |
Maloney IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy (1997) | Mar 24, 2017 | EXHIBIT | PETITIONER |
WO 95.03770 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Maloney et al., IDEC-C2B8 (1997) | Mar 24, 2017 | EXHIBIT | PETITIONER |
Edwards, The Predictable Effect of Small Immune Complexes | Mar 24, 2017 | EXHIBIT | PETITIONER |
Edwards, The case for Killing Cells with ANTI-CD20 in RA | Mar 24, 2017 | EXHIBIT | PETITIONER |
The University College London Hospitals, October 30, 1998 Letter | Mar 24, 2017 | EXHIBIT | PETITIONER |
Moreland Etanercept Therapy in Rheumatoid Arthritis | Mar 24, 2017 | EXHIBIT | PETITIONER |
Remicade Label 1998 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Wendler, Rituximab in Practice | Mar 24, 2017 | EXHIBIT | PETITIONER |
Edwards, Efficacy of B-Cell-Targeted Therapy (2004) | Mar 24, 2017 | EXHIBIT | PETITIONER |
EXPUNGED | Mar 24, 2017 | EXHIBIT | PETITIONER |
Bathon, Comparison of Etanercept and Methotrexate (2000) | Mar 24, 2017 | EXHIBIT | PETITIONER |
Gabriel, the Epidemiology of Rheumatoid Arthritis | Mar 24, 2017 | EXHIBIT | PETITIONER |
The Joint UCL,UCLH Committees on the Ethics of Human Research | Mar 24, 2017 | EXHIBIT | PETITIONER |
Letter from the Medicines Control Agency to Edwards | Mar 24, 2017 | EXHIBIT | PETITIONER |
Information for patients undergoing treatment of rheumatoid arthritis | Mar 24, 2017 | EXHIBIT | PETITIONER |
Rituxan label 1997 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Kremer (1995) | Mar 24, 2017 | EXHIBIT | PETITIONER |
Declaration by Jonathan Charles Wright Edwards | Mar 24, 2017 | EXHIBIT | PETITIONER |
FDA, 64 Fed. Reg. 7898 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Buch, Updated consensus statemetn on the use of rituximab | Mar 24, 2017 | EXHIBIT | PETITIONER |
Decision of the European Patent Office re-EP1179681 | Mar 24, 2017 | EXHIBIT | PETITIONER |
FDA, Rituxan Approval Letter, 97-0244 (November 26, 1997) | Mar 24, 2017 | EXHIBIT | PETITIONER |
1997 Form 10-K405.A filed by IDEC Pharmaceuticals | Mar 24, 2017 | EXHIBIT | PETITIONER |
Declaration from Internet Archive | Mar 24, 2017 | EXHIBIT | PETITIONER |
ODell, Treatment of Rheumatoid Arthritis with Methotrexate Alone | Mar 24, 2017 | EXHIBIT | PETITIONER |
Kalden, Rescue of DMARD Failure by Means of Monoclonal Antibodies | Mar 24, 2017 | EXHIBIT | PETITIONER |
Drugs@FDA, FDA Applciation No. (BLA) 103705 | Mar 24, 2017 | EXHIBIT | PETITIONER |
Internet Archive Capture of Genentech Website for Rituxan | Mar 24, 2017 | EXHIBIT | PETITIONER |
Pfizer, Inc.s Power of Attorney | Mar 24, 2017 | PAPER | PETITIONER |
MOTION FOR JOINDER | Mar 24, 2017 | PAPER | PETITIONER |
PETITION FOR INTER PARTES REVIEW | Mar 24, 2017 | PAPER | PETITIONER |